SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Patrizia Burra, Eleonora De Martin, Alberto Zanetto, Marco Senzolo, Francesco Paolo Russo, Giacomo Zanus, Stefano Fagiuoli, Hepatitis C virus and liver transplantation: where do we stand?, Transplant International, 2016, 29, 2
  2. 2
    Zoe Mariño, Maria-Carlota Londoño, Xavier Forns, Hepatitis C treatment for patients post liver transplant, Current Opinion in Organ Transplantation, 2015, 20, 3, 251

    CrossRef

  3. 3
    Audrey Coilly, Bruno Roche, Jean-Charles Duclos-Vallée, Didier Samuel, Management of post transplant hepatitis C in the direct antiviral agents era, Hepatology International, 2015, 9, 2, 192

    CrossRef

  4. 4
    Hyeyoung Kim, Kwang-Woong Lee, Nam-Joon Yi, Hae Won Lee, YoungRok Choi, Suk-Won Suh, Jaehong Jeong, Kyung-Suk Suh, Response-Guided Therapy for Hepatitis C Virus Recurrence Based on Early Protocol Biopsy after Liver Transplantation, Journal of Korean Medical Science, 2015, 30, 11, 1577

    CrossRef

  5. 5
    Marina Berenguer, John R. Lake, Transplantation of the Liver, 2015,

    CrossRef

  6. 6
    Gary L. Davis, Transplantation of the Liver, 2015,

    CrossRef

  7. 7
    J. Howell, P. Angus, P. Gow, Hepatitis C recurrence: the Achilles heel of liver transplantation, Transplant Infectious Disease, 2014, 16, 1
  8. You have free access to this content8
    Audrey Coilly, Bruno Roche, Jean-Charles Duclos-Vallée, Didier Samuel, Management of HCV transplant patients with triple therapy, Liver International, 2014, 34,
  9. 9
    Bruno Roche, Audrey Coilly, Jean-Charles Duclos-Vallée, Didier Samuel, Optimal Management of HCV Transplant Patients, Current Hepatology Reports, 2014, 13, 4, 304

    CrossRef

  10. 10
    H.M. Dabbous, M.S. Elmeteini, M.A. Sakr, I.F. Montasser, M. Bahaa, A. Abdelaal, M. Fathy, R. Refaie, M. Seyam, A. Abdelmonem, A. Mukhtar, N. Hegazy, M. Almoneiri, Optimizing Outcome of Recurrent Hepatitis C Virus Genotype 4 After Living Donor Liver Transplantation: Moving Forward by Looking Back, Transplantation Proceedings, 2014, 46, 3, 822

    CrossRef

  11. 11
    Mitsuhisa Takatsuki, Akihiko Soyama, Izumi Muraoka, Takanobu Hara, Ayaka Kinoshita, Izumi Yamaguchi, Takayuki Tanaka, Tamotsu Kuroki, Susumu Eguchi, Post-operative complications requiring hospitalization more than one yr after living donor liver transplantation , Clinical Transplantation, 2014, 28, 1
  12. You have free access to this content12
    Audrey Coilly, Bruno Roche, Didier Samuel, Current management and perspectives for HCV recurrence after liver transplantation, Liver International, 2013, 33,
  13. 13
    Susanne Beckebaum, Iyad Kabar, Vito R. Cicinnati, Hepatitis B and C in liver transplantation: new strategies to combat the enemies, Reviews in Medical Virology, 2013, 23, 3
  14. You have free access to this content14
    Elizabeth C. Verna, Hepatitis C virus: Management of recurrent disease, Clinical Liver Disease, 2013, 2, 4
  15. 15
    Nobuhisa Akamatsu, Yasuhiko Sugawara, Living-Donor Liver Transplantation and Hepatitis C, HPB Surgery, 2013, 2013, 1

    CrossRef

  16. 16
    Sung Won Lee, Si Hyun Bae, Management of Hepatitis C Viral Infection Pre- and Post-liver Transplantation, The Journal of the Korean Society for Transplantation, 2013, 27, 1, 1

    CrossRef

  17. 17
    Shih-Hsien Hsu, Ming-Lun Yeh, Shen-Nien Wang, New Insights in Recurrent HCV Infection after Liver Transplantation, Clinical and Developmental Immunology, 2013, 2013, 1

    CrossRef

  18. You have free access to this content18
    Tsunamasa Watanabe, Yasuhito Tanaka, Reactivation of hepatitis viruses following immunomodulating systemic chemotherapy, Hepatology Research, 2013, 43, 2
  19. You have free access to this content19
    D. Joshi, I. Carey, K. Agarwal, Review article: the treatment of genotype 1 chronic hepatitis C virus infection in liver transplant candidates and recipients, Alimentary Pharmacology & Therapeutics, 2013, 37, 7
  20. 20
    Rafael Bárcena, Ana Moreno, Miguel Angel Rodríguez-Gandía, Agustín Albillos, Carlos Arocena, Carlos Blesa, Fernando García-Hoz, Javier Graus, Javier Nuño, Pedro López-Hervás, Luis Gajate, Adolfo Martínez, Teresa Bermejo, María Luisa Mateos, Santos del Campo, Safety and anti-HCV effect of prolonged intravenous silibinin in HCV genotype 1 subjects in the immediate liver transplant period, Journal of Hepatology, 2013, 58, 3, 421

    CrossRef

  21. 21
    Ji-Yuan Zhang, Yuan-Yuan Li, Zheng Zhang, Fu-Sheng Wang, The prediction of immunological dysfunction during antiviral therapy for HCV after liver transplantation: can we improve outcomes?, Hepatology International, 2013, 7, 4, 948

    CrossRef

  22. 22
    Kosh Agarwal, Ashley Barnabas, Treatment of chronic hepatitis C virus infection after liver transplantation, Digestive and Liver Disease, 2013, 45, S349

    CrossRef

  23. 23
    J. Levitsky, K. Doucette, Viral Hepatitis in Solid Organ Transplantation, American Journal of Transplantation, 2013, 13, s4
  24. 24
    Tomohiro Tanaka, Nazia Selzner, George Therapondos, Eberhard L. Renner, Leslie B. Lilly, Virological response for recurrent hepatitis C improves long-term survival in liver transplant recipients, Transplant International, 2013, 26, 1
  25. You have free access to this content25
    Elizabeth C. Verna, Robert S. Brown, Hepatitis C viral infection after liver transplantation, Clinical Liver Disease, 2012, 1, 3
  26. 26
    Bruno Roche, Didier Samuel, Hepatitis C virus treatment pre- and post-liver transplantation, Liver International, 2012, 32,
  27. 27
    Nobuhisa Akamatsu, Yasuhiko Sugawara, Liver Transplantation and Hepatitis C, International Journal of Hepatology, 2012, 2012, 1

    CrossRef

  28. 28
    Manav Wadhawan, Sunil Taneja, Rajeev Shandil, Neerav Goyal, Subash Gupta, Ajay Kumar, Management of chronic hepatitis C before and after liver transplant, Apollo Medicine, 2012, 9, 1, 24

    CrossRef

  29. 29
    Fredric D. Gordon, Paul Kwo, Reem Ghalib, Jeffrey Crippin, Hugo E. Vargas, Kimberly A. Brown, Thomas Schiano, Eirum Chaudhri, Lisa D. Pedicone, Robert S. Brown, Peginterferon-α-2b and Ribavirin for Hepatitis C Recurrence Postorthotopic Liver Transplantation, Journal of Clinical Gastroenterology, 2012, 46, 8, 700

    CrossRef

  30. 30
    M. Palmer, R. Rubin, V. Rustgi, Randomised clinical trial: pre-dosing with taribavirin before starting pegylated interferon vs. standard combination regimen in treatment-naïve patients with chronic hepatitis C genotype 1, Alimentary Pharmacology & Therapeutics, 2012, 36, 4
  31. 31
    Marina Berenguer, Ramón Charco, Juan Manuel Pascasio, Jose Ignacio Herrero, Spanish society of liver transplantation (SETH) consensus recommendations on hepatitis C virus and liver transplantation, Liver International, 2012, 32, 5
  32. 32
    Shigeru Marubashi, Koji Umeshita, Toshimasa Asahara, Kenji Fujiwara, Hironori Haga, Takashi Hashimoto, Katsuyoshi Hatakeyama, Takafumi Ichida, Takashi Kanematsu, Masaki Kitajima, Kendo Kiyosawa, Masatoshi Makuuchi, Shinichi Miyagawa, Susumu Satomi, Yuji Soejima, Yasutsugu Takada, Noriaki Tanaka, Satoshi Teraoka, Morito Monden, Steroid-free living donor liver transplantation for HCV – a multicenter prospective cohort study in Japan, Clinical Transplantation, 2012, 26, 6
  33. 33
    Daniel Eyraud, Benjamin Granger, Christian Ionescu, Silvia Fratéa, Sabine Darnat, Jean-Christophe Vaillant, Jean-Michel Siksik, Laurent Hannoun, Pierre Coriat, Thrombocytopenia, splenomegaly, and portal blood flow in patients who have undergone liver transplantation for cirrhosis, Liver Transplantation, 2012, 18, 3
  34. 34
    Martin Lagging, Ann-Sofi Duberg, Rune Wejstål, Ola Weiland, Magnus Lindh, Soo Aleman, Filip Josephson, Treatment of hepatitis C virus infection in adults and children: Updated Swedish consensus recommendations, Scandinavian Journal of Infectious Diseases, 2012, 44, 7, 502

    CrossRef

  35. 35
    Hui-Hui Tan, Paul Martin, Care of the Liver Transplant Candidate, Clinics in Liver Disease, 2011, 15, 4, 779

    CrossRef

  36. 36
    III Consensus Meeting of the Spanish Society of Liver Transplantation. Hepatitis C, Living-donor Liver Transplantation, Quality of Liver Grafts and of Liver Transplantation Programs, Cirugía Española (English Edition), 2011, 89, 8, 487

    CrossRef

  37. 37
    J. Ignacio Herrero, III Reunión de consenso de la Sociedad Española de Trasplante Hepático (SETH). Hepatitis C, trasplante hepático de donante vivo, calidad de los injertos hepáticos y calidad de los programas de trasplante hepático, Gastroenterología y Hepatología, 2011, 34, 9, 641

    CrossRef

  38. 38
    III Reunión de consenso de la Sociedad Española de Trasplante Hepático (SETH). Hepatitis C, trasplante hepático de donante vivo, calidad de los injertos hepáticos y calidad de los programas de trasplante hepático, Cirugía Española, 2011, 89, 8, 487

    CrossRef

  39. 39
    Bruno Roche, Didier Samuel, Is early antiviral therapy for recurrent hepatitis C after liver transplantation superior to later treatment? The answer is no, Liver Transplantation, 2011, 17, 5
  40. 40
    A. Rubín, V. Aguilera, M. Berenguer, Liver transplantation and hepatitis C, Clinics and Research in Hepatology and Gastroenterology, 2011, 35, 12, 805

    CrossRef

  41. 41
    Julie A. Thompson, John R. Lake, Liver Transplantation for Hepatitis C: Disease Management, Current Hepatitis Reports, 2011, 10, 1, 41

    CrossRef

  42. 42
    J. A. Wertheim, H. Petrowsky, S. Saab, J. W. Kupiec-Weglinski, R. W. Busuttil, Major Challenges Limiting Liver Transplantation in the United States, American Journal of Transplantation, 2011, 11, 9
  43. 43
    F.R. Ponziani, A. Gasbarrini, M. Pompili, P. Burra, S. Fagiuoli, Management of Hepatitis C Virus Infection Recurrence After Liver Transplantation: An Overview, Transplantation Proceedings, 2011, 43, 1, 291

    CrossRef

  44. 44
    Alpna R. Limaye, Roberto J. Firpi, Management of Recurrent Hepatitis C Infection after Liver Transplantation, Clinics in Liver Disease, 2011, 15, 4, 845

    CrossRef

  45. 45
    Josh Levitsky, Olaf Guckelberger, Meeting Report of the 16th Annual International Congress of the International Liver Transplantation Society, Liver Transplantation, 2011, 17, 1
  46. 46
    Natalie Bzowej, David R. Nelson, Norah A. Terrault, Gregory T. Everson, Lichen L. Teng, Avinash Prabhakar, Michael R. Charlton, PHOENIX: A randomized controlled trial of peginterferon alfa-2a plus ribavirin as a prophylactic treatment after liver transplantation for hepatitis C virus, Liver Transplantation, 2011, 17, 5
  47. 47
    Saumya Jayakumar, Vincent Bain, Rational Guide to the Use of Erythropoietin in the Treatment of HCV Infection, Current Hepatitis Reports, 2011, 10, 1, 62

    CrossRef

  48. 48
    P. Guillouche, C. Féray, Systematic review: anti-viral therapy of recurrent hepatitis C after liver transplantation, Alimentary Pharmacology & Therapeutics, 2011, 33, 2
  49. 49
    Marina Berenguer, Treatment of hepatitis C in the post-transplant setting, Digestive and Liver Disease Supplements, 2011, 5, 1, 26

    CrossRef

  50. 50
    Jan Peveling-Oberhag, Stefan Zeuzem, Wolf Peter Hofmann, Antiviral therapy of chronic hepatitis C in patients with advanced liver disease and after liver transplantation, Medical Microbiology and Immunology, 2010, 199, 1, 1

    CrossRef

  51. 51
    Yasuhiko Sugawara, Sumihito Tamura, Norihiro Kokudo, Antiviral Treatment for Hepatitis C Virus Infection after Liver Transplantation, Hepatitis Research and Treatment, 2010, 2010, 1

    CrossRef

  52. 52
    Hokkaido Liver Transplantation Stud, Masahiko Taniguchi, Hiroyuki Furukawa, Tsuyoshi Shimamura, Tomomi Suzuki, Kenichiro Yamashita, Satoru Todo, Deceased donor liver transplantation, Kanzo, 2010, 51, 4, 143

    CrossRef

  53. 53
    W.-C. Lee, T.-J. Wu, H.-S. Chou, C.-F. Lee, K.-M. Chan, S.-S. Cheng, Flexible and individualized treatment to achieve sustained viral response for recurrent hepatitis C in liver transplant recipients, Journal of Viral Hepatitis, 2010, 17, 11
  54. 54
    Nyingi M. Kemmer, Tiffany E. Kaiser, Guy W. Neff, Hepatitis C After Liver Transplantation: Treatment and Impact on Patient and Graft Survival, Current Hepatitis Reports, 2010, 9, 3, 161

    CrossRef

  55. You have free access to this content55
    Bruno Roche, Didier Samuel, Hepatitis C virus: Up to the minute, Liver Transplantation, 2010, 16, S2
  56. 56
    Kimberly A. Brown, Natural History and Treatment of Hepatitis C in Liver Transplant Recipients, Current Hepatitis Reports, 2010, 9, 1, 30

    CrossRef

  57. 57
    Sumihito Tamura, Yasuhiko Sugawara, Noriyo Yamashiki, Junichi Kaneko, Norihiro Kokudo, Masatoshi Makuuchi, Pre-emptive antiviral therapy in living donor liver transplantation for hepatitis C: observation based on a single-center experience, Transplant International, 2010, 23, 6
  58. 58
    K. Inoue, T. Watanabe, M. Yamada, H. Yoshikumi, O. Ogawa, M. Yoshiba, Efficacy of Interferon β Combined With Cyclosporine Induction and Intensified Therapy for Retreatment of Chronic Hepatitis C, Transplantation Proceedings, 2009, 41, 1, 246

    CrossRef

  59. 59
    T.M. Antonini, D. Samuel, Indications et résultats de la greffe hépatique (hors carcinome hépatocellulaire et hépatite fulminante), Gastroentérologie Clinique et Biologique, 2009, 33, 1, 44

    CrossRef

  60. 60
    Masahiro Ohira, Minoru Ishifuro, Kentaro Ide, Toshimitsu Irei, Hirotaka Tashiro, Toshiyuki Itamoto, Katsuhide Ito, Kazuaki Chayama, Toshimasa Asahara, Hideki Ohdan, Significant correlation between spleen volume and thrombocytopenia in liver transplant patients: A concept for predicting persistent thrombocytopenia, Liver Transplantation, 2009, 15, 2
  61. 61
    Ka-Kit Li, James Neuberger, The management of patients awaiting liver transplantation, Nature Reviews Gastroenterology & Hepatology, 2009, 6, 11, 648

    CrossRef

  62. 62
    E. Balbi, C.R.G. Leal, L.F. Pacheco-Moreira, F.S. Pousa, M.C. Covelo, A.C. Gonzalez, P.V. Oliveira, L. Agoglia, J. Roma, L.P. Cariús, M. Enne, Treatment for Recurrent Hepatitis C Virus Infection After Liver Transplantation, Transplantation Proceedings, 2009, 41, 3, 891

    CrossRef

  63. 63
    Fredric D. Gordon, Paul Kwo, Hugo E. Vargas, Treatment of hepatitis C in liver transplant recipients, Liver Transplantation, 2009, 15, 2
  64. 64
    Gabriella Lengyel, Zsolt Tulassay, Treatment of recurrent hepatitis C virus infection in patients after liver transplantation, Clinical and Experimental Medical Journal, 2009, 3, 2, 237

    CrossRef

  65. 65
    J. Levitsky, K. Doucette, Viral Hepatitis in Solid Organ Transplant Recipients, American Journal of Transplantation, 2009, 9,
  66. 66
    Lucio Urbani, Alessandro Mazzoni, Piero Colombatto, Lucia Bindi, Gianni Biancofiore, Carlo Tascini, Francesco Menichetti, Maurizia Rossana Brunetto, Fabrizio Scatena, Franco Filipponi, A Novel Immunosuppressive Strategy Combined with Preemptive Antiviral Therapy Improves the Eighteen-Month Mortality in HCV Recipients Transplanted with Aged Livers, Transplantation, 2008, 86, 12, 1666

    CrossRef

  67. 67
    Elizabeth C. Verna, Robert S. Brown, Hepatitis C and Liver Transplantation: Enhancing Outcomes and Should Patients Be Retransplanted, Clinics in Liver Disease, 2008, 12, 3, 637

    CrossRef

  68. 68
    Norah A. Terrault, Hepatitis C therapy before and after liver transplantation, Liver Transplantation, 2008, 14, S2
  69. 69
    Matteo Cescon, Gian Luca Grazi, Alessandro Cucchetti, Matteo Ravaioli, Giorgio Ercolani, Marco Vivarelli, Antonietta D'Errico, Massimo Del Gaudio, Antonio Daniele Pinna, Improving the outcome of liver transplantation with very old donors with updated selection and management criteria, Liver Transplantation, 2008, 14, 5
  70. 70
    Bruno Roche, Didier Samuel, Liver transplantation in viral hepatitis: Prevention of recurrence, Best Practice & Research Clinical Gastroenterology, 2008, 22, 6, 1153

    CrossRef

  71. 71
    Alexander Kuo, Vivian Tan, Billy Lan, Mandana Khalili, Sandy Feng, John P. Roberts, Norah A. Terrault, Long-term histological effects of preemptive antiviral therapy in liver transplant recipients with hepatitis C virus infection, Liver Transplantation, 2008, 14, 10
  72. 72
    E. Xirouchakis, C. Triantos, P. Manousou, A. Sigalas, V. Calvaruso, A. Corbani, G. Leandro, D. Patch, A. Burroughs, Pegylated-interferon and ribavirin in liver transplant candidates and recipients with HCV cirrhosis: systematic review and meta-analysis of prospective controlled studies, Journal of Viral Hepatitis, 2008, 15, 10
  73. 73
    L. Urbani, A. Mazzoni, P. Colombatto, G. Biancofiore, L. Bindi, C. Tascini, F. Menichetti, M. Brunetto, F. Scatena, F. Filipponi, Potential Applications of Extracorporeal Photopheresis in Liver Transplantation, Transplantation Proceedings, 2008, 40, 4, 1175

    CrossRef

  74. 74
    L. Margusino Framiñán, F. Suárez López, I. Martín Herranz, Profilaxis y tratamiento de la hepatopatía por virus C en el entorno del trasplante hepático. Revisión narrativa, Farmacia Hospitalaria, 2008, 32, 2, 102

    CrossRef

  75. 75
    Toru Ikegami, Mitsuo Shimada, Satoru Imura, Recent role of splenectomy in chronic hepatic disorders, Hepatology Research, 2008, 38, 12
  76. 76
    Marina Berenguer, Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin, Journal of Hepatology, 2008, 49, 2, 274

    CrossRef

  77. 77
    Luis Margusino Framiñán, Francisco Suárez López, Isabel Martín Herranz, The Profilaxis and Treatment of C Virus Liver Disease in the Liver Transplantation Setting. Narrative Review, Farmacia Hospitalaria (English Edition), 2008, 32, 2, 102

    CrossRef

  78. You have free access to this content78
    Sumihito Tamura, Yasuhiko Sugawara, Treatment strategy for hepatitis C after liver transplantation, Journal of Hepato-Biliary-Pancreatic Surgery, 2008, 15, 2
  79. 79
    Thierry Thévenot, Jean-François Cadranel, Vincent Di Martino, Alexandre Pariente, Xavier Causse, Christophe Renou, Hervé Hagege, Jacques Denis, Françoise Lunel-Fabiani, A national French survey on the use of growth factors as adjuvant treatment of chronic hepatitis C, Hepatology, 2007, 45, 2
  80. 80
    Kamila Wojcik, Martin Vogel, Esther Voigt, Nicola Speidel, J??rg C Kalff, Georg Goldmann, Johannes Oldenburg, Tilman Sauerbruch, J??rgen Kurt Rockstroh, Ulrich Spengler, Antiviral therapy for hepatitis C virus recurrence after liver transplantation in HIV-infected patients: outcome in the Bonn cohort, AIDS, 2007, 21, 10, 1363

    CrossRef

  81. 81
    E. Jenny Heathcote, Antiviral therapy: chronic hepatitis C, Journal of Viral Hepatitis, 2007, 14,
  82. 82
    Mazen Alsatie, Naga Chalasani, Paul Y Kwo, Management of Hepatitis C Infection after Liver Transplantation, Drugs, 2007, 67, 6, 871

    CrossRef

  83. 83
    Marina Berenguer, Management of Hepatitis C Virus in the Transplant Patient, Clinics in Liver Disease, 2007, 11, 2, 355

    CrossRef

  84. 84
    R. R. ARJAL, J. R. BURTON JR, F. VILLAMIL, H. R. ROSEN, Review article: the treatment of hepatitis C virus recurrence after liver transplantation, Alimentary Pharmacology & Therapeutics, 2007, 26, 2
  85. 85
    Didier Samuel, Bruno Roche, Ribavirin in the treatment of recurrent hepatitis C after liver transplantation: Difficult to manage but essential for success, Journal of Hepatology, 2007, 46, 6, 988

    CrossRef

  86. 86
    Hirotaka Tashiro, Toshiyuki Itamoto, Hideki Ohdan, Yasuhiro Fudaba, Toshihiko Kohashi, Hironobu Amano, Kohei Ishiyama, Shoichi Takahashi, Hiroshi Aikata, Kazuaki Chayama, Koji Arihiro, Toshimasa Asahara, Should splenectomy be performed for hepatitis C patients undergoing living-donor liver transplantation?, Journal of Gastroenterology and Hepatology, 2007, 22, 6
  87. 87
    Rosângela Teixeira, Érica Godinho Menezes, Thomas D. Schiano, Therapeutic management of recurrent hepatitis C after liver transplantation, Liver International, 2007, 27, 3
  88. 88
    Douglas Meyer, Kirti Shetty, Treatment of recurrent hepatitis C following liver transplantation, Current Hepatitis Reports, 2007, 6, 2, 54

    CrossRef

  89. 89
    Gabriella Lengyel, Zsolt Tulassay, Treatment of recurrent hepatitis C virus infection after liver transplantation, Orvosi Hetilap, 2007, 148, 40, 1875

    CrossRef

  90. 90
    Marina Berenguer, Viral hepatitis after liver transplantation, Hepatology Research, 2007, 37,
  91. 91
    Gregory T. Everson, Clark C. Kulig, Antiviral therapy for hepatitis C in the setting of liver transplantation, Current Treatment Options in Gastroenterology, 2006, 9, 6, 520

    CrossRef

  92. 92
    A. Burke, Applicability, Tolerability and Efficacy of Preemptive Antiviral Therapy in Hepatitis C-Infected Patients Undergoing Liver Transplantation, Yearbook of Gastroenterology, 2006, 2006, 270

    CrossRef

  93. 93
    S. Feng, M. Barr, J. Roberts, R. Oberbauer, B. Kaplan, Developments in Clinical Islet, Liver Thoracic, Kidney and Pancreas Transplantation in the Last 5 Years, American Journal of Transplantation, 2006, 6, 8
  94. 94
    Carlos G Fasola, Goran B Klintmalm, Hepatitis C recurrence after liver transplantation: in search of the optimal immunosuppression to improve outcome, Current Opinion in Organ Transplantation, 2006, 11, 6, 637

    CrossRef

  95. 95
    E. Oton, R. Barcena, J. M. Moreno-Planas, V. Cuervas-Mons, A. Moreno-Zamora, C. Barrios, S. Garcia-Garzon, A. Moreno, E. Boullosa-Graña, E. E. Rubio-Gonzalez, M. Garcia-Gonzalez, C. Blesa, M. L. Mateos, Hepatitis C Recurrence After Liver Transplantation: Viral and Histologic Response to Full-Dose Peg-Interferon and Ribavirin, American Journal of Transplantation, 2006, 6, 10
  96. 96
    Elizabeth C. Verna, Robert S. Brown, Hepatitis C Virus and Liver Transplantation, Clinics in Liver Disease, 2006, 10, 4, 919

    CrossRef

  97. 97
    Marina Berenguer, Hepatitis C virus in liver transplantation: impact and treatment of hepatitis C virus recurrence, Current Opinion in Organ Transplantation, 2006, 11, 6, 599

    CrossRef

  98. 98
    Martin F Sprinzl, Gerd Otto, Peter R Galle, Marcus Schuchmann, Hepatitis C virus re-infection: new perspectives, Clinical Transplantation, 2006, 20,
  99. You have free access to this content99
    Shigeru Marubashi, Keizo Dono, Atsushi Miyamoto, Yutaka Takeda, Hiroaki Nagano, Koji Umeshita, Morito Monden, Liver transplantation for hepatitis C, Journal of Hepato-Biliary-Pancreatic Surgery, 2006, 13, 5
  100. 100
    Adnan Said, Michael R Lucey, Liver transplantation: an update, Current Opinion in Gastroenterology, 2006, 22, 3, 272

    CrossRef

  101. 101
    A. Kuo, N. A. Terrault, Management of Hepatitis C in Liver Transplant Recipients, American Journal of Transplantation, 2006, 6, 3
  102. 102
    Sakib K. Khalid, Jeffrey S. Crippin, Management of Hepatitis C in the Setting of Liver Transplantation, Clinics in Liver Disease, 2006, 10, 2, 321

    CrossRef

  103. 103
    Scott W. Biggins, Norah A. Terrault, Management of Recurrent Hepatitis C in Liver Transplant Recipients, Infectious Disease Clinics of North America, 2006, 20, 1, 155

    CrossRef

  104. 104
    Marina Berenguer, Manejo de la infección por el virus de la hepatitis C en el trasplante hepático, Gastroenterología y Hepatología, 2006, 29, 7, 422

    CrossRef

  105. 105
    R.J. Andrade, Manejo de los efectos adversos del tratamiento, Gastroenterología y Hepatología, 2006, 29, 184

    CrossRef

  106. 106
    M. Heydtmann, D. Freshwater, T. Dudley, V. Lai, S. Palmer, S. Hübscher, D. Mutimer, Pegylated Interferon Alpha-2b for Patients with HCV Recurrence and Graft Fibrosis Following Liver Transplantation, American Journal of Transplantation, 2006, 6, 4
  107. 107
    M. García-Retortillo, Prevención de la recidiva de la cirrosis hepática por el VHC. Un factor crítico para mejorar los resultados del trasplante hepático, Gastroenterología y Hepatología, 2006, 29, 3, 122

    CrossRef

  108. 108
    Didier Samuel, Xavier Forns, Marina Berenguer, Christian Trautwein, Andrew Burroughs, Mario Rizzetto, Christian Trepo, Report of the Monothematic EASL Conference on Liver Transplantation for Viral Hepatitis, Journal of Hepatology, 2006, 45, 1, 127

    CrossRef

  109. 109
    Harald Hofer, Calin Gurguta, Ulrike Bergholz, Petra Steindl-Munda, Peter Ferenci, Standard interferon-alpha in combination with ribavirin for hepatitis C patients with advanced liver disease and thrombocytopenia, Wiener klinische Wochenschrift, 2006, 118, 19-20, 595

    CrossRef

  110. 110
    M. Berenguer, Tratamiento de la hepatitis C antes y después del trasplante hepático, Gastroenterología y Hepatología, 2006, 29, 190

    CrossRef

  111. 111
    Norah A. Terrault, Marina Berenguer, Treating hepatitis C infection in liver transplant recipients, Liver Transplantation, 2006, 12, 8
  112. 112
    Lawrence U. Liu, Thomas D. Schiano, Adult Live Donor Liver Transplantation, Clinics in Liver Disease, 2005, 9, 4, 767

    CrossRef

  113. 113
    Christos Triantos, Dimitrios Samonakis, Rosa Stigliano, Ulrich Thalheimer, David Patch Andrew Burroughs, Antiviral Therapy for Recurrent Hepatitis C Infection after Liver Transplantation, Transplantation, 2005, 80, 4, 540

    CrossRef

  114. 114
    Marina Berenguer, Hepatitis C after liver transplantation: risk factors, outcomes, and treatment, Current Opinion in Organ Transplantation, 2005, 10, 2, 81

    CrossRef

  115. 115
    M Taniguchi, H Furukawa, T Shimamura, T Suzuki, K Yamashita, S Todo, Present condition of liver transplantation and future problem. 1. Living liver transplantation and brain death liver transplantation. Trend in the world and present state in our country., Kanzo, 2005, 46, 6, 299

    CrossRef

  116. 116
    Marina Berenguer, Treatment of Hepatitis C after Liver Transplantation, Clinics in Liver Disease, 2005, 9, 4, 579

    CrossRef

  117. 117
    Jens Encke, Thomas Kraus, Arianeb Mehrabi, Wolfgang Stremmel, Peter Sauer, Treatment of Hepatitis C Virus Reinfection after Liver Transplantation, Transplantation, 2005, 80, Supplement, S125

    CrossRef

  118. 118
    Scott W. Biggins, Norah A. Terrault, Treatment of Recurrent Hepatitis C After Liver Transplantation, Clinics in Liver Disease, 2005, 9, 3, 505

    CrossRef

  119. 119
    Michael P. Curry, Nezam H. Afdhal, Use of Growth Factors with Antiviral Therapy for Chronic Hepatitis C, Clinics in Liver Disease, 2005, 9, 3, 439

    CrossRef

  120. 120
    Kurinchi Selvan Gurusamy, Emmanuel Tsochatzis, Brian R Davidson, Andrew K Burroughs, Antiviral prophylactic intervention for chronic hepatitis C virus in patients undergoing liver transplantation, The Cochrane Library,
  121. 121
    Kurinchi Selvan Gurusamy, Emmanuel Tsochatzis, Clare D Toon, Brian R Davidson, Andrew K Burroughs, Antiviral prophylaxis for the prevention of chronic hepatitis C virus in patients undergoing liver transplantation, The Cochrane Library,
  122. 122
    Ed Gane, Liver Transplantation for Chronic Hepatitis B and C,
  123. 123
    Norah Terrault, Liver Transplantation in Patients with Hepatitis B, C or HIV Infection,
  124. 124
    Kiran Bambha, Norah A. Terrault, Long-Term Management of Recurrent Primary Liver Disease,
  125. 125
    Ed Gane, Prevention and Treatment of Recurrent HBV and HCV Infection,
  126. 126
    Ed Gane, Treatment of Recurrent Hepatitis C Following Liver Transplantation,